Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Messina

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Breast Cancer Research and Treatment|July 14, 2018
Towards treatment personalisation in triple negative breast cancer: role of platinum-based neoadjuvant chemotherapyMattia Rediti, Carlo Messina
Anti-Cancer Agents in Medicinal Chemistry|March 9, 2017
May Adjuvant Therapy Play A Role for the Management of Renal Cell Carcinoma? A Review of Literature and Ongoing TrialsCarlo Messina, Elisa Zanardi, Francesco Boccardo
European Urology|August 13, 2017
Abiraterone or Docetaxel for Castration-sensitive Metastatic Prostate Cancer? That Is the Question!Carlo Messina, Marco Messina, Francesco Boccardo
The Oncologist|December 22, 2020
In ReplyLucia Nappi, Margaret Ottaviano, Pasquale Rescigno, et al.
Future Oncology (London, England)|August 20, 2019
Sequencing strategies in the new treatment landscape of prostate cancerOrazio Caffo, Francesca Maines, Stefania Kinspergher, et al.
Expert Review of Anticancer Therapy|November 27, 2020
To treat or not to treat: is it acceptable to avoid active therapies in advanced prostate cancer today?Orazio Caffo, Francesca Maines, Stefania Kinspergher, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|March 12, 2004
Differences in the fretting corrosion of metal-metal and ceramic-metal modular junctions of total hip replacementsNadim James Hallab, Carlo Messina, Anastasia Skipor, et al.
Diagnostics (Basel, Switzerland)|November 27, 2021
Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: Role of the Radiologist and Oncologist in the Era of Precision MedicineFederica Vernuccio, Carlo Messina, Valeria Merz, et al.
Frontiers in Public Health|January 4, 2021
Medical Liability in Cancer Care During COVID-19 Pandemic: Heroes or Guilty?Rosario Barranco, Carlo Messina, Alessandro Bonsignore, et al.
Frontiers in Immunology|May 22, 2026
Editorial: Beyond therapeutic innovation in genitourinary cancers: the unmet need for biologically driven patient selectionBrigida Anna Maiorano, Linda Cerbone, Carlo Messina, et al.
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Breast Cancer Research and Treatment|July 14, 2018
Towards treatment personalisation in triple negative breast cancer: role of platinum-based neoadjuvant chemotherapyMattia Rediti, Carlo Messina
Anti-Cancer Agents in Medicinal Chemistry|March 9, 2017
May Adjuvant Therapy Play A Role for the Management of Renal Cell Carcinoma? A Review of Literature and Ongoing TrialsCarlo Messina, Elisa Zanardi, Francesco Boccardo
European Urology|August 13, 2017
Abiraterone or Docetaxel for Castration-sensitive Metastatic Prostate Cancer? That Is the Question!Carlo Messina, Marco Messina, Francesco Boccardo
The Oncologist|December 22, 2020
In ReplyLucia Nappi, Margaret Ottaviano, Pasquale Rescigno, et al.
Future Oncology (London, England)|August 20, 2019
Sequencing strategies in the new treatment landscape of prostate cancerOrazio Caffo, Francesca Maines, Stefania Kinspergher, et al.
Expert Review of Anticancer Therapy|November 27, 2020
To treat or not to treat: is it acceptable to avoid active therapies in advanced prostate cancer today?Orazio Caffo, Francesca Maines, Stefania Kinspergher, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|March 12, 2004
Differences in the fretting corrosion of metal-metal and ceramic-metal modular junctions of total hip replacementsNadim James Hallab, Carlo Messina, Anastasia Skipor, et al.
Diagnostics (Basel, Switzerland)|November 27, 2021
Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: Role of the Radiologist and Oncologist in the Era of Precision MedicineFederica Vernuccio, Carlo Messina, Valeria Merz, et al.
Frontiers in Public Health|January 4, 2021
Medical Liability in Cancer Care During COVID-19 Pandemic: Heroes or Guilty?Rosario Barranco, Carlo Messina, Alessandro Bonsignore, et al.
Frontiers in Immunology|May 22, 2026
Editorial: Beyond therapeutic innovation in genitourinary cancers: the unmet need for biologically driven patient selectionBrigida Anna Maiorano, Linda Cerbone, Carlo Messina, et al.
Pageof 11